Physician

Adrian Eoin Omalley, MD

According to 2025 Medicare claims, Adrian Omalley, MD (NPI: 1295729010) practices ophthalmology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is PACIFIC NORTHWEST RETINA PLLC (NPI: 1558940387; TIN: 853763379) and primary practice location at 98383-7849.

Omalley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,291 traditional Medicare patients, billed 40,687 HCPCS/CPT codes, and received $4,064,301 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 148 prescription claims across 92 beneficiaries totaling $5,238 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 2 records totaling $242. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $18,027 to $5,238. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.1M2015 Medicare payment: $3,046,077 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,964,928 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,767,248 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,625,286 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,696,671 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,522,396 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,452,098 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,426,513 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,029,437 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,064,301 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201596714,708$3,046,077
20161,04714,426$2,964,928
20171,11114,011$2,767,248
20181,18913,537$2,625,286
20191,20713,937$2,696,671
20201,02012,478$2,522,396
20211,13412,669$2,452,098
20221,26713,725$2,426,513
20231,26126,325$3,029,437
20241,29140,687$4,064,301

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.0K$18K2015 Drug cost: $18,027 (USD; Tot_Drug_Cst)2016 Drug cost: $10,649 (USD; Tot_Drug_Cst)2017 Drug cost: $6,341 (USD; Tot_Drug_Cst)2018 Drug cost: $10,484 (USD; Tot_Drug_Cst)2019 Drug cost: $6,210 (USD; Tot_Drug_Cst)2020 Drug cost: $5,960 (USD; Tot_Drug_Cst)2021 Drug cost: $5,401 (USD; Tot_Drug_Cst)2022 Drug cost: $3,892 (USD; Tot_Drug_Cst)2023 Drug cost: $6,362 (USD; Tot_Drug_Cst)2024 Drug cost: $5,238 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201558162$18,027
201666193$10,649
201750154$6,341
201860190$10,484
201956105$6,210
20205895$5,960
202165114$5,401
202265118$3,892
202381133$6,362
202492148$5,238

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2391,496$656
67028Injection of drug into eye5032,012$97
92014Established patient complete exam of visual system483549$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more543962$68
92134Imaging of retina1,1673,278$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate18713$1,994
Prednisolone AcetatePrednisolone Acetate261,374$1,338
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha581,359$616
LatanoprostLatanoprost201,091$307
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat141,234$115

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$242Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adrian Eoin Omalley, MD?

Tedicare shows public-source Medicare data for Adrian Eoin Omalley, MD (NPI 1295729010), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Eoin Omalley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adrian Eoin Omalley, MD?

Adrian Eoin Omalley, MD is linked to PACIFIC NORTHWEST RETINA PLLC (billing NPI 1558940387) in the available physician profile data.

Does Adrian Eoin Omalley, MD have Open Payments data?

Adrian Eoin Omalley, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.